BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18367956)

  • 1. Percutaneous liver biopsy in hemophiliac children with chronic hepatitis C virus infection.
    Schwarz KB; Zellos A; Stamato L; Boitnott J; Perlman E; Chong S; Casella JF
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):423-8. PubMed ID: 18367956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lyophilized cryoprecipitate for children with hemophilia A.
    Nuchprayoon I; Sahasittiwat S; Kittikalayawong A; Chantanakajornfung A
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S293-7. PubMed ID: 12188426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus safety of pasteurized factor VIII and factor IX concentrates: study in virgin patients.
    Heimburger N; Karges HE; Weidmann E
    Dev Biol Stand; 1987; 67():303-10. PubMed ID: 3038638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hemophilia.
    Rodeghiero F
    Ric Clin Lab; 1985; 15(4):289-303. PubMed ID: 3914697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous infusion of factor VIII for surgery and major bleeding.
    Hay CR; Doughty HI; Savidge GF
    Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S15-9. PubMed ID: 8735792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complications of percutaneous liver biopsy in patients after liver transplantation].
    Lang M; Neumann UP; Müller AR; Bechstein WO; Neuhaus R; Neuhaus P
    Z Gastroenterol; 1999 Mar; 37(3):205-8. PubMed ID: 10234792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Viral hepatitis in hemophiliac patients treated with commercial concentrates of factors VIII and IX].
    Miranda ML; Lissen E; Vinuesa M; Jiménez JM; García de Pesquera F; Leal M
    Med Clin (Barc); 1985 Apr; 84(13):516-9. PubMed ID: 3923278
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylaxis in haemophilic children.
    Liesner RJ
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S7-10. PubMed ID: 9351529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regimens of factor VIII administration--continuous infusion vs. bolus.
    Berntorp E
    Haematologica; 2000 Oct; 85(10 Suppl):69-71; discussion 71-2. PubMed ID: 11187875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal purified F VIII for continuous infusion: stability, microbiological safety and clinical experience.
    Schulman S; Varon D; Keller N; Gitel S; Martinowitz U
    Thromb Haemost; 1994 Sep; 72(3):403-7. PubMed ID: 7855792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Severe complications of percutaneous hepatic biopsy in patients with orthotopic liver transplantation].
    Pérez Roldán F; Bañares R; Clemente G; Alvarez E; Casado M; de Diego A; González Asanza C; Valdecantos E; Ferreiroa J; Calleja J
    Gastroenterol Hepatol; 1995 Oct; 18(8):410-2. PubMed ID: 7584779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-over pharmacokinetic study of a double viral inactivated factor IX concentrate (15 nm filtration and SD) compared to a SD factor IX concentrate.
    Goudemand J; Peynet J; Chambost H; Négrier C; Briquel ME; Claeyssens S; Derlon-Borel A; Guérois C; Caron C; Scherrmann JM; Debray M; Bridey F
    Thromb Haemost; 1998 Dec; 80(6):919-24. PubMed ID: 9869161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired hemophilia A after liver transplantation: a case report.
    Hisatake GM; Chen TW; Renz JF; Farmer DG; Ghobrial RM; Yersiz H; Amado RG; Goldstein L; Busuttil RW
    Liver Transpl; 2003 May; 9(5):523-6. PubMed ID: 12740798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications of percutaneous liver biopsy.
    Wawrzynowicz-Syczewska M; Kruszewski T; Boron-Kaczmarska A
    Rom J Gastroenterol; 2002 Jun; 11(2):105-7. PubMed ID: 12145665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The administration of factor VIII concentrates to hemophiliacs by continuous perfusion pump].
    Rodríguez Bueno S; Montoro Ronsano JB; Martínez Sánchez B; Altisent Roca C; Tusell Puigvert JM
    Med Clin (Barc); 1991 Mar; 96(10):364-6. PubMed ID: 1904520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anesthetic management of a patient with hemophilia A for left modified Blalock-Taussig shunt].
    Ejima Y; Satoh S; Hoshi K; Hasegawa R; Matsukawa S; Hashimoto Y
    Masui; 2000 Jan; 49(1):30-2. PubMed ID: 10689839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver assessment and biopsy in patients with marked coagulopathy: value of mini-laparoscopy and control of bleeding.
    Denzer U; Helmreich-Becker I; Galle PR; Lohse AW
    Am J Gastroenterol; 2003 Apr; 98(4):893-900. PubMed ID: 12738474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).
    Cadranel JF; Rufat P; Degos F
    Hepatology; 2000 Sep; 32(3):477-81. PubMed ID: 10960438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family issues in continuous infusion therapy with factor VIII.
    Manco-Johnson MJ
    Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S21-5. PubMed ID: 8735793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular access in hemophilia.
    Powell TW; Blumoff RL; Mandel SR
    Am Surg; 1981 Sep; 47(9):408-9. PubMed ID: 6792959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.